Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
AquaGold quarterly for the high-end work, at-home microinfusion bi-weekly in between for maintenance
The upper outer area of your arms (if someone else is administering the injection)
Providing a treatment option that is proven to lower this cardiovascular risk is a major advance for public health. The FDAs decision is largely based on data from the SELECT trial, which included more than 17,000 overweight or obese patients with a baseline age of 45 years old
, NEJMoa2505669
NCT03548987
Saxenda was approved for weight management in December 2014 and has been shown to contribute to approximately 5% reduction in body weight
US$ 25.95
US$ 21.59
US$ 22.26
US$ 27.18
US$ 27.76
